Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Association of Flavored Tobacco Use With Tobacco Initiation and Subsequent Use Among US Youth and Adults, 2013-2015.

Villanti AC, Johnson AL, Glasser AM, Rose SW, Ambrose BK, Conway KP, Cummings KM, Stanton CA, Edwards KC, Delnevo CD, Wackowski OA, Feirman SP, Bansal-Travers M, Bernat JK, Holder-Hayes E, Green VR, Silveira ML, Hyland A.

JAMA Netw Open. 2019 Oct 2;2(10):e1913804. doi: 10.1001/jamanetworkopen.2019.13804.

2.

Flavour types used by youth and adult tobacco users in wave 2 of the Population Assessment of Tobacco and Health (PATH) Study 2014-2015.

Rose SW, Johnson AL, Glasser AM, Villanti AC, Ambrose BK, Conway K, Cummings KM, Stanton CA, Delnevo C, Wackowski OA, Edwards KC, Feirman SP, Bansal-Travers M, Bernat J, Holder-Hayes E, Green V, Silveira ML, Zhou Y, Abudayyeh H, Hyland A.

Tob Control. 2019 Sep 21. pii: tobaccocontrol-2018-054852. doi: 10.1136/tobaccocontrol-2018-054852. [Epub ahead of print]

PMID:
31542778
3.

Re: Disregarding the impact of nicotine on the developing brain when evaluating costs and benefits of noncombustible nicotine products.

Abrams DB, Glasser AM, Villanti AC, Pearson JL, Rose S, Niaura RS.

Prev Med. 2019 Mar;120:158-159. doi: 10.1016/j.ypmed.2018.12.027.

PMID:
30738502
4.

Managing nicotine without smoke to save lives now: Evidence for harm minimization.

Abrams DB, Glasser AM, Villanti AC, Pearson JL, Rose S, Niaura RS.

Prev Med. 2018 Dec;117:88-97. doi: 10.1016/j.ypmed.2018.06.010. Epub 2018 Jun 23.

PMID:
29944902
5.

Impact of Question Type and Question Order on Tobacco Prevalence Estimates in US Young Adults: A Randomized Experiment.

Johnson AL, Villanti AC, Glasser AM, Pearson JL, Delnevo CD.

Nicotine Tob Res. 2019 Jul 17;21(8):1144-1146. doi: 10.1093/ntr/nty058.

6.

Adolescent tobacco coupon receipt, vulnerability characteristics and subsequent tobacco use: analysis of PATH Study, Waves 1 and 2.

Rose SW, Glasser AM, Zhou Y, Cruz TB, Cohn AM, Lienemann BA, Byron MJ, Huang LL, Meissner HI, Baezconde-Garbanati L, Unger JB.

Tob Control. 2018 Jul;27(e1):e50-e56. doi: 10.1136/tobaccocontrol-2017-054141. Epub 2018 Feb 22.

7.

Fostering transparency in e-cigarette research synthesis: the utility and limitations of methodological hierarchies.

Villanti AC, Niaura RS, Pearson JL, Glasser AM, Abrams DB.

Addiction. 2018 Mar;113(3):409-410. doi: 10.1111/add.14143. No abstract available.

PMID:
29423991
8.

Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives.

Abrams DB, Glasser AM, Pearson JL, Villanti AC, Collins LK, Niaura RS.

Annu Rev Public Health. 2018 Apr 1;39:193-213. doi: 10.1146/annurev-publhealth-040617-013849. Epub 2018 Jan 11.

PMID:
29323611
9.

E-Cigarette Marketing and Communication: How E-Cigarette Companies Market E-Cigarettes and the Public Engages with E-cigarette Information.

Collins L, Glasser AM, Abudayyeh H, Pearson JL, Villanti AC.

Nicotine Tob Res. 2019 Jan 1;21(1):14-24. doi: 10.1093/ntr/ntx284.

10.

Social and substance use correlates of adult hookah use, 2016.

Abudayyeh HS, Glasser AM, Johnson AL, Cohn AM, Wagener TL, Mays D, Villanti AC.

Addict Behav. 2018 Apr;79:39-44. doi: 10.1016/j.addbeh.2017.12.011. Epub 2017 Dec 9. No abstract available.

11.

Establishing consensus on survey measures for electronic nicotine and non-nicotine delivery system use: Current challenges and considerations for researchers.

Weaver SR, Kim H, Glasser AM, Sutfin EL, Barrington-Trimis J, Payne TJ, Saddleson M, Loukas A.

Addict Behav. 2018 Apr;79:203-212. doi: 10.1016/j.addbeh.2017.11.016. Epub 2017 Nov 16. Review.

12.

How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor.

Villanti AC, Feirman SP, Niaura RS, Pearson JL, Glasser AM, Collins LK, Abrams DB.

Addiction. 2018 Mar;113(3):391-404. doi: 10.1111/add.14020. Epub 2017 Oct 3.

PMID:
28975720
13.

Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013-14).

Pearson JL, Johnson AL, Johnson SE, Stanton CA, Villanti AC, Niaura RS, Glasser AM, Wang B, Abrams DB, Cummings KM, Hyland A.

Addiction. 2018 Jan;113(1):113-124. doi: 10.1111/add.13952. Epub 2017 Sep 6.

14.

Recommended core items to assess e-cigarette use in population-based surveys.

Pearson JL, Hitchman SC, Brose LS, Bauld L, Glasser AM, Villanti AC, McNeill A, Abrams DB, Cohen JE.

Tob Control. 2018 May;27(3):341-346. doi: 10.1136/tobaccocontrol-2016-053541. Epub 2017 Jun 17.

PMID:
28624764
15.

Frequency of Youth E-Cigarette, Tobacco, and Poly-Use in the United States, 2015: Update to Villanti et al., "Frequency of Youth E-Cigarette and Tobacco Use Patterns in the United States: Measurement Precision Is Critical to Inform Public Health".

Collins LK, Villanti AC, Pearson JL, Glasser AM, Johnson AL, Niaura RS, Abrams DB.

Nicotine Tob Res. 2017 Oct 1;19(10):1253-1254. doi: 10.1093/ntr/ntx073. No abstract available.

16.

Computational Models Used to Assess US Tobacco Control Policies.

Feirman SP, Glasser AM, Rose S, Niaura R, Abrams DB, Teplitskaya L, Villanti AC.

Nicotine Tob Res. 2017 Nov 1;19(11):1257-1267. doi: 10.1093/ntr/ntx017. Review.

PMID:
28339561
17.

Flavored Tobacco Product Use in Youth and Adults: Findings From the First Wave of the PATH Study (2013-2014).

Villanti AC, Johnson AL, Ambrose BK, Cummings KM, Stanton CA, Rose SW, Feirman SP, Tworek C, Glasser AM, Pearson JL, Cohn AM, Conway KP, Niaura RS, Bansal-Travers M, Hyland A.

Am J Prev Med. 2017 Aug;53(2):139-151. doi: 10.1016/j.amepre.2017.01.026. Epub 2017 Mar 16.

18.

Frequency of Youth E-Cigarette and Tobacco Use Patterns in the United States: Measurement Precision Is Critical to Inform Public Health.

Villanti AC, Pearson JL, Glasser AM, Johnson AL, Collins LK, Niaura RS, Abrams DB.

Nicotine Tob Res. 2017 Nov 1;19(11):1345-1350. doi: 10.1093/ntr/ntw388.

19.

Misperceptions of harm among Natural American Spirit smokers: results from wave 1 of the Population Assessment of Tobacco and Health (PATH) study (2013-2014).

Pearson JL, Johnson A, Villanti A, Glasser AM, Collins L, Cohn A, Rose SW, Niaura R, Stanton CA.

Tob Control. 2017 Mar;26(e1):e61-e67. doi: 10.1136/tobaccocontrol-2016-053265. Epub 2016 Dec 6.

PMID:
27924008
20.

Overview of Electronic Nicotine Delivery Systems: A Systematic Review.

Glasser AM, Collins L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, Villanti AC.

Am J Prev Med. 2017 Feb;52(2):e33-e66. doi: 10.1016/j.amepre.2016.10.036. Epub 2016 Nov 30. Review.

21.

Medical costs and quality-adjusted life years associated with smoking: a systematic review.

Feirman SP, Glasser AM, Teplitskaya L, Holtgrave DR, Abrams DB, Niaura RS, Villanti AC.

BMC Public Health. 2016 Jul 27;16:646. doi: 10.1186/s12889-016-3319-z. Review.

22.

Mathematical Modeling in Tobacco Control Research: Initial Results From a Systematic Review.

Feirman SP, Donaldson E, Glasser AM, Pearson JL, Niaura R, Rose SW, Abrams DB, Villanti AC.

Nicotine Tob Res. 2016 Mar;18(3):229-42. doi: 10.1093/ntr/ntv104. Epub 2015 May 14. Review.

PMID:
25977409
23.

Electronic nicotine delivery devices, and their impact on health and patterns of tobacco use: a systematic review protocol.

Glasser AM, Cobb CO, Teplitskaya L, Ganz O, Katz L, Rose SW, Feirman S, Villanti AC.

BMJ Open. 2015 Apr 29;5(4):e007688. doi: 10.1136/bmjopen-2015-007688.

24.

Pricing health behavior interventions to promote adoption: lessons from the marketing and business literature.

Ribisl KM, Leeman J, Glasser AM.

Am J Prev Med. 2014 Jun;46(6):653-9. doi: 10.1016/j.amepre.2014.02.008.

25.

Therapies for Children With Autism Spectrum Disorders.

Warren Z, Veenstra-VanderWeele J, Stone W, Bruzek JL, Nahmias AS, Foss-Feig JH, Jerome RN, Krishnaswami S, Sathe NA, Glasser AM, Surawicz T, McPheeters ML.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Apr.

26.

Paradoxical hypertensive effect on papaverine and nitroglycerine on the distal blood pressure of an occluded brain artery in the dog.

De Micheli P, Glässer AM.

Pharmacol Res Commun. 1977 Feb;9(2):173-9. No abstract available.

PMID:
405677

Supplemental Content

Loading ...
Support Center